Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
Clinical trial NCT02574455 · COMPLETED
Trial details
- NCT number
- NCT02574455
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2020-03-30
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.